Lab now supporting COVID-19 testing efforts in response to the pandemic
Our team has over 20 years of experience building and operating high-complexity CLIA laboratories. Members of our team have brought multiple tests to market, particularly novel prostate cancer diagnostics. We are closely affiliated with the University of Michigan.
LynxDx, a biotechnology startup, is committed to the health of our community during the COVID-19 pandemic. We have focused our diagnostic laboratory to provide testing at-scale, particularly for our most vulnerable and high-risk populations.
Your facility has a physician’s order that permits patient samples to be collected
A medical professional collects patient samples via nasal or oral swab
Samples are packaged in transport media and sent to our laboratory
Our CLIA-licensed lab processes the samples using RNA isolation and PCR
Results are reported back to your facility within 24 hours
CLIA-certified (high complexity)
qPCR-based antigen detection
24-hour turnaround time
Both nasopharyngeal and
Reimbursable by insurance
Can process hundreds